Novoray Corporation

SHSE:688300 Voorraadrapport

Marktkapitalisatie: CN¥9.2b

Novoray Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Novoray has a total shareholder equity of CN¥1.4B and total debt of CN¥97.4M, which brings its debt-to-equity ratio to 6.8%. Its total assets and total liabilities are CN¥1.9B and CN¥477.5M respectively. Novoray's EBIT is CN¥245.7M making its interest coverage ratio -18.1. It has cash and short-term investments of CN¥420.8M.

Belangrijke informatie

6.8%

Verhouding schuld/eigen vermogen

CN¥97.40m

Schuld

Rente dekkingsratio-18.1x
ContantCN¥420.81m
AandelenCN¥1.44b
Totaal verplichtingenCN¥477.46m
Totaal activaCN¥1.92b

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Recent updates

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

Oct 18
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26
What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Jul 29
Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Jul 13
What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Jun 19
Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27
When Should You Buy Novoray Corporation (SHSE:688300)?

Analyse van de financiële positie

Kortlopende schulden: 688300's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥316.5M).

Langlopende schulden: 688300's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥161.0M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688300 has more cash than its total debt.

Schuld verminderen: 688300's debt to equity ratio has reduced from 7.8% to 6.8% over the past 5 years.

Schuldendekking: 688300's debt is well covered by operating cash flow (254.7%).

Rentedekking: 688300 earns more interest than it pays, so coverage of interest payments is not a concern.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y